Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease.
D000328:Adult; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy / Q000378:metabolism; D007457:Iodine Radioisotopes; D008135:Long-Acting Thyroid Stimulator / Q000097:blood; D011441:Propylthiouracil / Q000009:adverse effects* / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000378:metabolism; D013963:Thyroid Hormones / Q000627:therapeutic use; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D013997:Time Factors; D014284:Triiodothyronine / Q000378:metabolism
D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D014284:Triiodothyronine; D011441:Propylthiouracil; D013972:Thyrotropin; D008135:Long-Acting Thyroid Stimulator; D013974:Thyroxine